GROWTH UNCHECKED: A Call to Action for Policymakers to Reform 340B, to Stop It from Driving Up Health Care Costs for Employers, Working Families and Taxpayers

This report from the American Benefits Council examines the impact of the exponential growth of the 340B Drug Pricing Program on employers and their workers. With nearly 180 million Americans covered by employer-sponsored health plans, a careful examination of the impact of the 340B program on employers and working families is essential in evaluating the true cost of the program and in considering legislation to reform it.